Inventors with similar research interests:
Location History:
- San Jose, CA (US) (1977)
- Gaithersburg, MD (US) (2006 - 2015)
- Westbury, NY (US) (2021)
- Rockville, MD (US) (2023)
- Bethesda, MD (US) (2009 - 2024)
Company Filing History:
60 out of 130 
1 out of 2 
2 out of 832,843 Years Active: 1977-2024
Areas of Expertise:
Title: Innovations of Ling Ling Huang: A Leader in Biopharmaceutical Patents
Introduction: Ling Ling Huang is an accomplished inventor based in San Jose, CA, known for his substantial contributions to the field of biopharmaceuticals. With 62 patents to his name, Huang has made significant strides in developing novel therapeutic approaches, particularly in cancer treatment and autoimmune diseases.
Latest Patents: Among Huang's most recent inventions are two groundbreaking patents. The first patent focuses on CD3-binding molecules capable of binding to both human and non-human CD3. This innovation is particularly notable for its cross-reactivity with CD3 of non-human mammals, such as cynomolgus monkeys, and offers promising applications in treating cancer, autoimmune disorders, and inflammatory diseases. The second patent pertains to HER2/neu-specific antibodies, particularly chimeric 4D5 antibodies that have reduced glycosylation compared to existing 4D5 antibodies. This invention also details methods for utilizing these antibodies in the diagnosis and treatment of various diseases, including cancers and autoimmune disorders.
Career Highlights: Ling Ling Huang has played a pivotal role in advancing therapeutic biologics during his career. His extensive experience in the biopharmaceutical sector has allowed him to innovate and improve treatment options for complex diseases. His contributions have cemented his reputation as a leading inventor in the field.
Collaborations: Huang has collaborated with notable professionals in the biopharmaceutical industry. Two of his coworkers, Leslie Sydnor Johnson and Ezio Bonvini, have contributed to his research efforts and innovations. Such collaborations enhance the development of his inventive concepts and accelerate advancements in therapeutic treatments.
Conclusion: With a remarkable portfolio of 62 patents, Ling Ling Huang stands out as a significant innovator in biopharmaceuticals. His inventions, particularly focused on treatment methodologies for complex diseases, continue to influence the healthcare landscape. His collaborative efforts highlight the importance of teamwork in fostering innovation and advancing therapeutic solutions.